16
Jun
2020
18:00
BST
Webinar
CCM® Around the World
-
Views:
31
-
Likes:
0
Overview
This live online webinar is an educational program designed to share the latest updates on a breakthrough device-based therapy for the treatment of moderate to severe heart failure. While cardiac contractility modulation using the Optimizer® device has been well-studied, published and widely available in Europe for a number of years, it was only recently approved in the US. The use of CCM® therapy continues to expand rapidly – which makes now a perfect time to bring the world's most experienced investigators and providers with extensive clinical experience together to discuss the current and future place CCM® may take in the treatment of heart failure.
Faculty:
Thomas M Helms
Karl-Heinz Kuck
William T Abraham
Daniel Burkhoff
Frieder Braunschweig
Jürgen Kuschyk
This webinar is supported by
Agenda
Learning Objectives
- Become aware of the history of Impulse Dynamics and it's founding by a renowned scientist inventor.
- Appreciate the extensive scientific endeavours that resulted in the outcomes that have driven approval by the various regulatory authorities.
- Learn about the mode of action that underpins CCM® therapy.
- Understand the clinical path forward for CCM® therapy.
- Gain an understanding of appropriate patient identification and selection.
- Share patient experiences via case studies presented by the physician with the most extensive clinical experience in the world.
Faculty Biographies
Karl-Heinz Kuck
Prof Dr Karl-Heinz Kuck is the head of the Department of Cardiology at the Asklepios Klinik in Hamburg.
He has earned several prizes for his work, including the Science Prize of the Gertrud Spitz Foundation and a silver badge of honor from the German Society for Cardiology – Heart and Circulatory Research. Prof Dr Kuck is also Section Editor – Clinical Electrophysiology and Ablation at Arrhythmia & Electrophysiology Review.
William T Abraham
Dr William T Abraham, MD, FACP, FACC, is a Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine at the Ohio State University College of Medicine. He also serves as Deputy Director of the Dorothy M Davis Heart and Lung Research Institute.
Dr Abraham previously held faculty appointments at the University of Colorado, the University of Cincinnati, and the University of Kentucky. Dr Abraham’s research interests include the role of the kidney in heart failure, neurohormonal mechanisms in heart failure, sleep-disordered breathing in heart failure, and clinical drug and device trials in heart failure and cardiac transplantation. He has received grants from the National Institutes of Health (NIH), the American College of Cardiology (ACC), and the Aetna Quality Care Foundation, and has participated as Principal Investigator in more than 100 multicenter clinical drug and device trials.
In addition to authoring more than 600 original papers, abstracts, book chapters, and review articles, Dr Abraham has co-edited a leading textbook on heart failure entitled Heart Failure: A Practical Approach to Treatment. He serves on the Editorial Boards of several major journals, including Congestive Heart Failure and Journal Watch Cardiology. He is also a scientific reviewer for such publications as Circulation, the European Heart Journal, and the Journal of the American College of Cardiology.
Dr Abraham has been recognized as one of the ‘Best Doctors in America’ for six consecutive years. He received his MD from Harvard Medical School, before completing a residency in internal medicine and fellowships in cardiology and heart failure/cardiac transplantation at the University of Colorado Health Sciences Center. He is board-certified in internal medicine and cardiovascular diseases.